Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study

The aim of this work is to present a case study where the failure of IVM 3.15 % and DRM 1 % to prevent natural infestations of C. hominivorax larvae in Argentina is investigated based on field efficacy tests and a pharmacokinetic and pharmacodynamic analysis. Thirty male crossbred Braford calves wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Muchiut, Sebastian, Miró, Maria Victoria, Anziani, Oscar Sergio, Nava, Santiago, Lifschitz, Adrian Luis
Formato: Artículo
Lenguaje:Inglés
Publicado: Elsevier 2025
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12123/21628
https://www.sciencedirect.com/science/article/abs/pii/S0304401724002735
https://doi.org/10.1016/j.vetpar.2024.110384
_version_ 1855486793955147776
author Muchiut, Sebastian
Miró, Maria Victoria
Anziani, Oscar Sergio
Nava, Santiago
Lifschitz, Adrian Luis
author_browse Anziani, Oscar Sergio
Lifschitz, Adrian Luis
Miró, Maria Victoria
Muchiut, Sebastian
Nava, Santiago
author_facet Muchiut, Sebastian
Miró, Maria Victoria
Anziani, Oscar Sergio
Nava, Santiago
Lifschitz, Adrian Luis
author_sort Muchiut, Sebastian
collection INTA Digital
description The aim of this work is to present a case study where the failure of IVM 3.15 % and DRM 1 % to prevent natural infestations of C. hominivorax larvae in Argentina is investigated based on field efficacy tests and a pharmacokinetic and pharmacodynamic analysis. Thirty male crossbred Braford calves were randomly assigned to three experimental groups (n = 10), the IVM 3.15 % group (subcutaneously at 630 µg/kg), the DRM 1 % group (subcutaneously at 200 µg/kg) and the control group (saline solution subcutaneously). All treatments were performed at the time of castration surgery through a scrotal incision, and the wounds were exposed to natural infestations of C. hominivorax. Wound inspections were carried out on days 3, 6, and 13 post-treatments. Jugular blood samples were taken from experimental animals at 3- and 6-days post-treatment. In presence of C. hominivorax larvae, samples of both the larvae and wound secretions were collected in plastic vials on days 3 and 6 to measure concentrations of both drugs by high-performance liquid chromatography. On day 3 post-treatment, active myiasis was observed in 9 animals from the control group, 5 from the IVM 3.15 % group, and 6 from the DRM 1 % group. On day 6 post-treatment, 5 and 3 new myiasis were detected in the IVM 3.15 % and DRM 1 % group, respectively. No larvae were observed in the wounds on day 13 post-treatment. Interestingly, DRM concentrations tended to be higher in larvae compared to IVM on day 3 post-treatment (p = 0.051), and IVM plasma concentrations tended to be higher than those measured for DRM on day 6 (p = 0.087). There was a very strong correlation between DRM and IVM concentrations in plasma and wound secretions and larvae. The uptake of DRM from wound secretions to larvae was 83 % greater than that of IVM (p = 0.03). The results of this trial suggest the presence of C. hominivorax resistance to DRM and highlight concern about the lack of effectiveness of IVM 3.15 % in preventing C. hominivorax infestations.
format Artículo
id INTA21628
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher Elsevier
publisherStr Elsevier
record_format dspace
spelling INTA216282025-03-12T13:10:10Z Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study Muchiut, Sebastian Miró, Maria Victoria Anziani, Oscar Sergio Nava, Santiago Lifschitz, Adrian Luis Cochliomyia hominivorax Insects Ivermectin Cattle Pharmacokinetics Pharmacodynamics Insectos Ivermectina Ganado Bovino Farmacocinética Farmacodinámica Doramectina Doramectin The aim of this work is to present a case study where the failure of IVM 3.15 % and DRM 1 % to prevent natural infestations of C. hominivorax larvae in Argentina is investigated based on field efficacy tests and a pharmacokinetic and pharmacodynamic analysis. Thirty male crossbred Braford calves were randomly assigned to three experimental groups (n = 10), the IVM 3.15 % group (subcutaneously at 630 µg/kg), the DRM 1 % group (subcutaneously at 200 µg/kg) and the control group (saline solution subcutaneously). All treatments were performed at the time of castration surgery through a scrotal incision, and the wounds were exposed to natural infestations of C. hominivorax. Wound inspections were carried out on days 3, 6, and 13 post-treatments. Jugular blood samples were taken from experimental animals at 3- and 6-days post-treatment. In presence of C. hominivorax larvae, samples of both the larvae and wound secretions were collected in plastic vials on days 3 and 6 to measure concentrations of both drugs by high-performance liquid chromatography. On day 3 post-treatment, active myiasis was observed in 9 animals from the control group, 5 from the IVM 3.15 % group, and 6 from the DRM 1 % group. On day 6 post-treatment, 5 and 3 new myiasis were detected in the IVM 3.15 % and DRM 1 % group, respectively. No larvae were observed in the wounds on day 13 post-treatment. Interestingly, DRM concentrations tended to be higher in larvae compared to IVM on day 3 post-treatment (p = 0.051), and IVM plasma concentrations tended to be higher than those measured for DRM on day 6 (p = 0.087). There was a very strong correlation between DRM and IVM concentrations in plasma and wound secretions and larvae. The uptake of DRM from wound secretions to larvae was 83 % greater than that of IVM (p = 0.03). The results of this trial suggest the presence of C. hominivorax resistance to DRM and highlight concern about the lack of effectiveness of IVM 3.15 % in preventing C. hominivorax infestations. EEA Rafaela Fil: Muchiut, Sebastian. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Rafaela. Instituto de Investigación de la Cadena Láctea (IDICAL); Argentina Fil: Muchiut, Sebastian. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigación de la Cadena Láctea (IDICAL); Argentina Fil: Miró, María Victoria. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil; Argentina Fil: Miró, María Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigación Veterinaria de Tandil (CIVETAN); Argentina Fil: Miró, María Victoria. Provincia de Buenos Aires. Comisión de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina Fil: Anziani, Oscar Sergio. Universidad Católica de Córdoba. Facultad Ciencias Agropecuarias. Laboratorio de Parasitología y Enfermedades Parasitarias; Argentina Fil: Nava, Santiago. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Rafaela. Instituto de Investigación de la Cadena Láctea (IDICAL); Argentina Fil: Nava, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigación de la Cadena Láctea (IDICAL); Argentina Fil: Lifschitz, Adrian. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Centro de Investigación Veterinaria de Tandil (CIVETAN); Argentina. Fil: Lifschitz, Adrian. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigación Veterinaria de Tandil (CIVETAN); Argentina Fil: Lifschitz, Adrian. Provincia de Buenos Aires. Comisión de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; Argentina 2025-03-12T13:07:25Z 2025-03-12T13:07:25Z 2025-02 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/21628 https://www.sciencedirect.com/science/article/abs/pii/S0304401724002735 0304-4017 1873-2550 https://doi.org/10.1016/j.vetpar.2024.110384 eng info:eu-repo/semantics/restrictedAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) application/pdf Elsevier Veterinary Parasitology 334 : 110384. (February 2025)
spellingShingle Cochliomyia hominivorax
Insects
Ivermectin
Cattle
Pharmacokinetics
Pharmacodynamics
Insectos
Ivermectina
Ganado Bovino
Farmacocinética
Farmacodinámica
Doramectina
Doramectin
Muchiut, Sebastian
Miró, Maria Victoria
Anziani, Oscar Sergio
Nava, Santiago
Lifschitz, Adrian Luis
Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study
title Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study
title_full Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study
title_fullStr Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study
title_full_unstemmed Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study
title_short Failure of doramectin and ivermectin in preventing Cochliomyia hominivorax myiasis in a subtropical region: A pharmacokinetic-pharmacodynamic study
title_sort failure of doramectin and ivermectin in preventing cochliomyia hominivorax myiasis in a subtropical region a pharmacokinetic pharmacodynamic study
topic Cochliomyia hominivorax
Insects
Ivermectin
Cattle
Pharmacokinetics
Pharmacodynamics
Insectos
Ivermectina
Ganado Bovino
Farmacocinética
Farmacodinámica
Doramectina
Doramectin
url http://hdl.handle.net/20.500.12123/21628
https://www.sciencedirect.com/science/article/abs/pii/S0304401724002735
https://doi.org/10.1016/j.vetpar.2024.110384
work_keys_str_mv AT muchiutsebastian failureofdoramectinandivermectininpreventingcochliomyiahominivoraxmyiasisinasubtropicalregionapharmacokineticpharmacodynamicstudy
AT miromariavictoria failureofdoramectinandivermectininpreventingcochliomyiahominivoraxmyiasisinasubtropicalregionapharmacokineticpharmacodynamicstudy
AT anzianioscarsergio failureofdoramectinandivermectininpreventingcochliomyiahominivoraxmyiasisinasubtropicalregionapharmacokineticpharmacodynamicstudy
AT navasantiago failureofdoramectinandivermectininpreventingcochliomyiahominivoraxmyiasisinasubtropicalregionapharmacokineticpharmacodynamicstudy
AT lifschitzadrianluis failureofdoramectinandivermectininpreventingcochliomyiahominivoraxmyiasisinasubtropicalregionapharmacokineticpharmacodynamicstudy